European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Metastasis from endometrial carcinoma to bilateral breasts presenting as inflammatory breast lesions
1 Department of Medical Oncology, First Affiliated Hospital of Medical College of of Xi'an Jiaotong University, Shaanxi Province
2 Department of Surgical Oncology, First Affiliated Hospital of Medical College of of Xi'an Jiaotong University, Shaanxi Province (P. R. China)
Eur. J. Gynaecol. Oncol. 2011, 32(5), 563–566;
Published: 10 October 2011
Background: Endometrial carcinoma rarely metastasizes to the bilateral breasts and presents as an inflammatory breast lesion. In this paper, we report a case of bilateral breast metastatic endometrial carcinoma and describe the clinical and pathological features. It is the second case of this kind of disease and the first case report with full clinical data. Case report: A 56-year-old Chinese woman (G3, P3) with endometrial carcinoma received cytoreductive surgery and chemotherapy. Approximately 22 months later, she presented with pain in the right axillary region and edema of the right breast. The pathology report confirmed multifocal invasive papillary adenocarcinoma of the right mammary gland, consistent with endometrial carcinoma metastasis. Although she received many lines of chemotherapy, the disease still progressed and metastasized to the contralateral breast. Gefitinib (Iressa) improved symptoms temporarily. Conclusions: Bilateral breasts metastasis of endometrial carcinoma is rare and difficult to treat. Molecular targeted therapy may be an effective treatment for breast metastasis.